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ABSTRACT 
Integration and communication of diverse information into human health assessments 
is often challenging given the wide variety of data types and sources under consideration. In 
this study, several new approaches are utilized for compiling and visualizing chemical 
structure and toxicological assay-derived information in support of both category and 
analogue read-across. A case study of propylene-based (P-series) glycol ethers was chosen, 
representing high production volume chemicals with a large database that includes 
physicochemical properties and various measures of mammalian toxicity. As a comparator, 
ethylene-based (E-series) glycol ethers were used to examine the potential for category 
separation and broader structural groupings. Two approaches for integrating and visualizing 
these complex data were used, Toxicological Priority Index (ToxPi) and Chemical-Biological 
Read-Across (CBRA), which allow for the unique incorporation of various types of data, 
differential weighting, relative ranking, and step retention to maximize transparency. The raw 
toxicity study data were transformed, scaled, and rendered to compose visualizations with 
alternate category grouping scenarios. We found overall that the glycol ethers group together 
within their structure-based category, as well as within series. Both ToxPi and CBRA 
facilitate effective communication of complex data and enable groupings and selection of 
most suitable analogues for read-across. 
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1. INTRODUCTION  
Whether to reduce the reliance on in vivo test models, build a constructive case for the 
application of read-across, or to develop a compliant submission for regulatory approval, the 
demand for integration and communication of modeled and experimentally-derived data has 
become a common challenge. In addition, most commodity chemicals that are being 
registered under the EU REACH (Registration, Evaluation, Authorization and Restriction of 
Chemicals) Regulation have some data gaps, primarily the information from experimental 
toxicity studies in animal models. These gaps need to be addressed before a robust safety 
assessment can be made.  Read-across has become the go-to method for filling information 
gaps for one substance based on the data of another substance; usually one that is structurally 
similar, contains the same functional group, or exhibits similar toxicological and/or 
environmental fate properties ((Berggren et al., 2015), European Chemicals Agency, 2011). 
Often when implementing read-across, data from structure activity relationships (SARs) are 
utilized as predictors based on an analog’s behavior under a given set of conditions, 
molecular descriptors, known activity, and prior testing of the analog(s) (Niska et al., 2008). 
The European Chemicals Agency (ECHA) points out repeatedly that “structural 
similarity is a necessary [but not sufficient] pre-requisite for any prediction based on read-
across under REACH” (European Chemicals Agency, 2015). Furthermore, it is advised in the 
same document that “for a read-across adaptation to be assessed and potentially accepted by 
the Agency, registrants have to show with clear reasoning and supporting data, that the 
substances involved in the read-across are structurally similar and are likely to have similar 
properties (or follow a similar pattern).” Thus, among many challenges in building a 
convincing read-across case, two are of a particular prominence to both the regulated 
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community and the regulators: (i) the inherent limitations of relying solely on structure and 
physico-chemical property information to justify “similarity”, and (ii) the diversity of the 
information comprising a read-across application given the wide variety of data types and 
sources used to justify the “similar properties (or follow a similar pattern)” clause. Though 
each successive submission strives to improve the read-across application method, there are 
hindrances to creating a full and accurate representation from modeled data alone (Ball et al., 
2014, Niska et al., 2008, Patlewicz et al., 2014). It has been suggested that some of these 
drawbacks can be mediated by the addition of in vitro to in vivo data (Low et al., 2014). 
Others, such as Hewitt et al. in 2010, have pointed out the benefits of integrating a 
combination of in silico models with a weight-of-evidence approach. Their use of (Q)SAR 
models such as CAESAR alongside the Derek expert system showed efficacy relevance, but 
echoed the limitations associated with an incomplete or limited dataset. (Hewitt et al., 2010) 
(Hewitt, Ellison, Enoch, Madden and Cronin, 2010) (Hewitt, Ellison, Enoch, Madden and 
Cronin, 2010)  
Regardless of the data types that are used in read-across, it “must be, in all cases, 
justified scientifically and documented thoroughly” and  “there may be several lines of 
evidence used to justify the read-across, with the aim of strengthening the case” (European 
Chemicals Agency, 2013). The requirement for “thorough documentation” of the scientific 
arguments that support the weight-of-evidence argument in read-across, or any other type of 
human health assessments, usually results in a voluminous amount of text, tables and charts 
that is difficult to communicate. The challenge of communicating the details of the extensive 
database that leads to a regulatory decision has been considered by several recent committees 
of the National Research Council (National Research Council, 2014, National Research 
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Council, 2015). This is increasingly pertinent as the 1976 Toxic Substances Control Act has 
undergone reform adding emphasis on utilizing emerging technologies to reduce and replace 
some of the traditional in vivo models. In addition, it calls for chemical grouping “into 
scientifically appropriate categories in cases in which testing of a chemical substance would 
provide scientifically valid and useful information on other chemical substances in the 
category.” This synthesizes the increase in emerging data types with the need for integration 
leading to a read-across evaluation (H.R.2576, 2016). Several approaches for data integration 
have recently been proposed to handle challenges presented by high-dimensional toxicity 
data. Formal meta-analytic approaches are not immediately applicable because information 
from different data streams is not directly comparable. A variety of methods exist for 
weighting multiple streams of evidence differently, from largely qualitative, such as Hill 
criteria, to statistical frameworks and weighting schemes (Linkov et al., 2015). Examples of 
approaches to categorize chemicals that are both quantitative and incorporate expert 
judgment include the Toxicological Prioritization Index (ToxPi) (Reif et al., 2010, Reif et al., 
2013) and Chemical-Biological Read-Across (CBRA) (Low et al., 2013). 
In this study, we aimed to apply ToxPi and CBRA to grouping and analogue selection 
using a case study of glycol ethers. Glycol ethers are present in many products that we 
encounter daily, with their ubiquity ranging from pharmaceuticals and cosmetics to paints, 
adhesives and cleaning products (Oxygenated Solvent Producers Association (OSPA), 2012). 
They are synthesized by the reaction of an alkene oxide with a primary alcohol of varying 
lengths. The main chain can be lengthened by further reacting with excess alkene oxides to 
create mono-, di-, and tri- glycol ethers with methyl, ethyl, propyl and longer carbon groups. 
Not only is there similarity in structure, physicochemical properties, as well as environmental 
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and biological fate, but there are also extensive data on their toxicity from a variety of 
mammalian, in vitro and ecological models (European Centre for Ecotoxicology and 
Toxicology of Chemicals, 2005, The Dow Chemical Company, 2013). A previous study used 
read-across and tiered exposure assessment in risk assessment for one glycol ether, 1-
methoxypropan-2-ol (PGME), as a representative for phase-in substances to be registered 
under REACH (Vink et al., 2010) and concluded that a robust data set provided by 
structurally related category members can predict missing values where needed. Here, we 
intend to expand these analyses to additional compounds in two broader categories, 
propylene (P-) and ethylene (E-) series glycol ethers and show how ToxPi and CBRA 
facilitate effective communication of complex data and enable groupings and selection of 
potential analogues suitable for a read-across application.  
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2. MATERIALS AND METHODS 
2.1 Chemical Selection 
The chemicals were chosen based on structural similarity, availability of data, and 
prevalence throughout industrial and consumer applications (see Table 1). Initially, eight P-
series glycol ethers  were chosen based on structural variety to better elucidate potential 
trends, and data availability to better represent and increase weight behind a trend, if found. 
After the initial integration, eight select E-series glycol ethers were added for comparison 
based on their structural similarity to the original P-series compounds. 
 
 
Table 1. Glycol ether compounds analyzed in this study. A comprehensive collection organized by 
either propylene-based (P-) or ethylene-based (E-) series, oxide units (Mono-, Di-, Tri-), and then side 
chain (methyl, ethyl, butyl) with the structure shown on the right. Structures in the table are derived 
from the respective REACH dossier by CAS number. Where multiple constituents were available, the 
primary was chosen. 
Chemical name CAS No. Abbrev. Series 
Oxide 
Units 
-OH 
chain 
Structure 
1-methoxypropan-2-ol 107-98-2 PGME P Mono methyl  
1-ethoxypropan-2-ol 1569-02-4 PGEE P Mono ethyl  
1-butoxypropan-2-ol 5131-66-8 PGBE P Mono butyl 
 
(2-methoxymethylethoxy)-1-propanol 34590-94-8 DPGME P Di methyl  
(2-Ethoxymethylethoxy)propanol 30025-38-8 DPGEE P Di ethyl  
1-(2-butoxy-1-methylethoxy)-propan-2-ol 29911-28-2 DPGBE P Di butyl  
2-[2-(2-methoxy-1-methylethoxy)-1-
methylethoxy] propan-1-ol 
25498-49-1 TPGME P Tri methyl  
1-[2-(2-butoxy-1-methylethoxy)-1-
methylethoxy]propan-1-ol 
55934-93-5 TPGBE P Tri butyl  
1-hydroxy-2-methoxyethane 109-86-4 EGME E Mono methyl  
2-ethoxyethanol 110-80-5 EGEE E Mono ethyl  
2-butoxyethanol 111-76-2 EGBE E Mono butyl  
2-(2-Methoxyethoxy) 111-77-3 DEGME E Di methyl  
2-(2-Ethoxyethoxy)ethanol 111-90-0 DEGEE E Di ethyl  
2-(2-Butoxyethoxy)ethanol 112-34-5 DEGBE E Di butyl  
2-[2-(2-methoxyethoxy)ethoxy] ethanol 112-35-6 TEGME E Tri methyl  
2-[2-(2-butoxyethoxy)ethoxy] ethanol 143-22-6 TEGBE E Tri butyl  
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2.2 Data Acquisition and Transformation 
First, the data from a variety of toxicological studies on selected compounds were 
collected from the disseminated REACH registration dossiers and assembled into a single 
spreadsheet matrix where each row was assigned to a specific chemical, and the individual 
columns represent distinct endpoints. Since many mammalian and ecotoxicity endpoints 
were evaluated for only a few compounds in the comparison, a criteria was set to only 
include parameters for which >40% of the data was available across the 16 compounds in the 
analysis, resulting in 21 endpoints being used for evaluation. This lead to certain traditional 
data being excluded, such as genotoxicity, to improve the competence of the overall 
comparison. The data for the additional E-series glycol ethers were also taken from the 
disseminated REACH dossiers documents (http://echa.europa.eu/web/guest/information-on-
chemicals/registered-substances).  
The data were compiled and organized into three test parameter categories: 
physicochemical properties, environmental toxicity, and mammalian toxicity. Again, due to 
data availability, only generated physicochemical and collected mammalian toxicity data 
were used. A modified Globally Harmonized System (GHS)-like classification for the 
categorization of chemicals was implemented (see Appendix Table 1) for endpoints which 
were not already given a published GHS hazard classification label. To equate the 
supplemented data to the existing GHS values, a reclassification system was devised to relate 
the raw data into a comparably scaled format.  The resulting data were then normalized to be 
bounded by the interval [0, 1] to be compatible with the ToxPi input requirements. To ensure 
the transformations were an accurate representation of the original data, an original 
spreadsheet was maintained separate from the working spreadsheets and periodically checked 
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for accuracy to the original documents, as well as the working spreadsheets for the data 
representations. Each parameter is treated separately when rescaling, rendering it unitless, 
facilitating the integration of multiple data types by eliminating the need for unit conversions 
or other compensatory actions. 
 
2.3 Toxicological Priority Index Data Integration and Visualization 
The resulting toxicity data table was uploaded into ToxPi GUI ((Reif et al., 2013), 
available for download from http://comptox.us/toxpi.php) and slice composition determined 
by clustering of data types. The Mammalian Toxicity data rendered five categories as seen in 
Table 2 (with the number of representative endpoints in parenthesis): Acute Toxicity (5), 
Irritation (3), Reproductive Toxicity (4), Developmental Toxicity (3), and Repeat Dose 
Toxicity (6).  The weighting scheme was chosen to reflect the number of parameters 
contributing to each slice; the more data inputs forming the slice, the larger the slice weight 
in composition, giving each endpoint an equal weight in the overall score. The ToxPi output 
not only consists of a pie chart representation for each chemical with the various endpoints as 
slices, but also includes a ranking of the chemicals, comparatively most to least toxic, based 
on the cumulative ToxPi score. After the information was processed, the outputs were 
organized in various ways to convey multiple aspects of the dataset and of the outcome. This 
was done by overlaying the resulting individual glycol ether ToxPis onto their corresponding 
data points on the graph of chemical rank vs. ToxPi score. This allowed for the combination 
of ToxPi output visuals to better elucidate potential trends. The resulting graphics were 
compared to the original dataset to ensure that the normalizations and visualizations had 
accurately rendered the information.  
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Acute Toxicity                  
LD50 (oral): Rat 0 0 0 0 0 0 0 0  .25 .25 .25 0 0 0 0 0 
LC50 (inhalation): Rat 0 0 0 0 0 0 0 -  .25 .5 .25 .5 0 0 0 0 
LD50 (dermal): Rabbit 0 0 0 0 0 0 0 0  .25 0 .25 0 0 0 0 0 
Hematopoietic Toxicity 0 0 0 0 0 0 0 0  0 0 1 0 0 0 0 0 
Hemolysis  0 0 0 0 0 0 0 0  1 1 0 0 0 0 0 0 
Irritation                  
Skin Irritation 0 0 .75 0 0 0 0 0  0 .25 .75 0 0 .25 0 0 
Eye Irritation 0 .75 .75 0 0 0 0 0  .25 .25 .75 0 .25 .75 0 1 
Skin Sensitization  0 0 0 0 0 0 0 0  0 0 0 0 0 0 - - 
Reproductive Toxicity                  
NOAEL (oral): Rat 0 - - - 0 0 - -  1 1 0 0 0 0 - - 
NOAEC (inhalation): Rodent 0 0 - - - - 0 -  .75 .25 0 - - - - - 
NOAEL (dermal): Rodent - - - - - .25 - -  .25 - - - - - - - 
Testicular Toxicity 0 0 0 0 0 0 0 0  1 1 0 1 1 0 0 0 
Developmental Toxicity                  
NOAEL (oral): Rat 0 - - - - 0 - -  1 .5 0 .75 0 0 0 0 
NOAEC (inhalation): Rodent 0 0 - 0 0 - 0 -  1 1 0 - - - - - 
NOAEL (dermal): Rodent - - 0 - - .25 - -  .75 - - - 0 0 - - 
Repeat Dose Toxicity                  
Sub-acute NOAEL (oral): Rat 0 0 0 .25 0 .25 - .25  .75 .25 .5 .25 .25 .25 0 - 
Sub-acute NOAEC (inhalation): Rat 0 0 0 0 - .25 0 -  .5 0 0 - .75 .5 - - 
Sub-acute NOAEL (dermal): Rabbit 0 - - 0 - - - -  .25 0 - - - - 0 0 
Sub-chronic NOAEL (oral): Rat 0 0 .25 - .25 .25 - .25  .75 .5 .75 - .5 .5 0 - 
Sub-chronic NOAEC (inhalation): Rat 0 0 0 0 - - 0 -  .75 .25 .5 0 .75 .75 - - 
Sub-chronic NOAEL (dermal): Rabbit 0 0 .25 0 - .25 .25 -  .25 - .5 .75 .25 .5 0 - 
 
Table 2. Rescaled mammalian toxicity data. A GHS-like format was applied to the values 
from the in vivo endpoints acquired (see Supplemental Table 1) to provide a binned 
evaluation, whose values were then rescaled within the range [0, 1]. 
 
2.4 Chemical Descriptors 
For each of the glycol ethers, two methodologies were used to describe the 
compounds by quantitative structural attributes to provide a standardized assessment of 
inherent properties in common, such as bond strength or length. Constant and near constant 
descriptors as well as highly correlated descriptors were excluded and descriptor values were 
normalized on a scale from 0 to 1. The Chemistry Development Kit (CDK) produced 85 
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relevant chemical descriptors, while Dragon provided 535 for chemical comparison 
(Steinbeck et al., 2003; Mauri et al., 2006).  
 
2.5 Principal Component Analysis 
The chemical descriptor data were used to perform separate Principal Component 
Analyses to separate out the planes of greatest global separation and look for a structural 
correlation if a trend was found. The plots were created using the open source software 
environment R (R Core Team, 2015).   
 
2.6 Chemical-Biological Read-Across Data Integration and Visualization 
After formatting the biological descriptors generated from the mammalian toxicity 
data and chemical descriptors into separate text files, they were loaded into the CBRA 
graphical user interface (http://www.fourches-laboratory.com/#!software/vkttx) and 
visualized. The application’s results show an individual chemical and the closest neighbors 
with respect to separate biological and chemical similarity. The visual created is a radial plot 
with the most similar chemicals closer to the center and top of each half of the chemical’s 
representative plot. A calculated Tanimoto coefficient is the similarity determinant value and 
corresponding vector length. The outputs can be visually refined by number of neighbors or 
by Tanimoto coefficient threshold for each plot; however, we chose to present the data for 
the five nearest neighbors to the compound of interest.  
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3. RESULTS 
 
The challenge surrounding confidence in the use of read-across analyses has been 
frequently scrutinized as lacking characterization of the factors that may contribute to 
uncertainty in the analogue (Patlewicz et al., 2013; Patlewicz et al., 2015). While most often 
the read-across analysis begins with identification of the chemical similarity (Wu et al., 
2010), assessment of the comparative biological activity is usually a secondary consideration, 
if discussed at all. While the basis for read-across is a lack of information for a certain 
endpoint, data gaps exist for most compounds; the reality is a checkerboard of missing data 
even among the well-defined libraries of chemicals. Thus, we evaluated the overall 
“similarity” among two closely related groups of chemicals, P- and E-series glycol ethers 
(Table 1), in terms of their likeness when considering biological (i.e., mammalian toxicity 
studies), chemical (i.e., 2D chemical descriptors), and combined  datasets. 
 
3.1. Biological Similarity 
 We used a complement of mammalian toxicity data on the selected compounds (see 
Table 2) to rank, group, and produce integrated visualizations of the results.  
First, we utilized the Toxicological Priority Index (ToxPi), a tool for transparent integration 
and visualization of data across disparate information domains (Reif et al., 2010; Reif et al., 
2013). ToxPi produces a dimensionless index score that enables multiple sources of evidence 
to be integrated into visual rankings that are transparent and facilitate decision making. 
Specifically, data were translated into ToxPi scores for all compounds, first independently for 
P- or E-series glycol ethers (Figure 1), and then by combining all compounds into one 
analysis (Figure 2).  
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Figure 1. ToxPi analysis of separate E- and P-series glycol ethers. ToxPi scores were used to create a relative 
rank of chemicals within each series for categories of mammalian toxicity. Visualization of the ToxPi-based 
groupings and trends are seen within P-series glycol ethers (A) and E-series glycol ethers (B) score/rank graphs. 
The individual ToxPi image was overlaid onto the corresponding rank/score. The greatest determinant in the P-
series comparison can be attributed to repeat dose toxicity. The largest similarity in E-series compounds comes 
from the intrinsic chemical properties (the quantity of groups, i.e., mono-, di- and tri-) and creates a spectrum 
rather than clusters. The inset shows the components of each slice: data type and number of endpoints (in 
parentheses). 
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Figure 2. ToxPi analysis of combined P- and E-series glycol ethers. The ToxPi-based groupings among mono- (blue dots), 
di- (green dots), and tri- (red dots) glycol ethers are shown for the entire dataset, along with the individual ToxPi images (A) 
or clouds highlighting structural similarity (B). Even when combined with P-series, the E-series mono-glycols are still 
relatively more biologically active, especially within the Acute Toxicity (red slice) category. The demonstrated structure-
activity relationships among glycol ether presents mono-glycols (blue cloud) as relatively most biologically active, with tri-
glycols (red cloud) being the least, especially within their respective series (P- or E-). 
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The resulting ToxPi visualizations are comprised of both the pie chart representation 
of toxicity, as well as the graph comparing the chemical’s rank (1 = least toxic, 8 or 16 = 
most toxic) to the ToxPi score (an integrated value of the attributed slice area). The larger the 
slice, the higher its biological activity in given mammalian toxicity tests comprising the slice. 
The small inner circle defined by the white-to-black gradient represents the percent missing 
data contributing to the ranking. The darker the shade of the inner slice, the more missing 
data, and therefore the less assurance that may be had in a true representation of toxicity 
rank.  
First, by comparing the P-series and E-series glycol ethers separately within their own 
set, we observed several groupings and trends. In Figure 1A the butyl ethers (abbreviations 
ending in “BE”) are relatively more toxic, largely due to high Acute and Repeat Dose 
Toxicity scores. Overall, the P-series cumulative toxicity profiles fall in a gradient rather than 
distinctly clustering by structural similarity. Conversely in Figure 1B, groupings based on 
wedge magnitude are apparent among the E-series ethers, illustrated by the red Acute 
Toxicity slice being relatively large only for the mono-glycols (EGME, EGEE, and EGBE). 
This shows the E-series separating by the mono-, di-, or tri-glycol chemical property, with 
the mono-glycols being overall more toxic, and the tri-glycols being the relatively least toxic.  
Next, we combined the P- and E- series data and re-analyzed the ToxPi results using 
the same criteria and grouping of individual assays with the increased dataset. Two trends in 
the grouping of agents based on their biological activity are evident, largely in concert with 
the chemical similarity (Figures 2A-B). The P-series ToxPi labels are shown below their 
corresponding points while the E-series labels are displayed above the points. Figure 2A 
displays each individual chemical’s ToxPi overlaying the corresponding Rank and Score. 
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Figure 2B layers the chemical similarity onto the toxicity data-based ToxPi ranking. The 
Acute Toxicity category is still driving the mono- E-series glycol ethers to be most toxic, 
even when combined with additional compounds. Figure 2B shows the E-series (squares) 
tended to have higher ToxPi scores (indicating relatively higher toxicity in the tests that were 
included in this analysis) than the P-series (circles) overall, which placed them further to the 
right on the x-axis. It is evident that there are sub-clusters of P- and E- series mono- (blue 
cloud), di- (green cloud) and tri-glycols (red cloud), with the mono-glycols exhibiting 
relatively higher toxicity for both sets overall.  
 
3.2. Chemical Similarity 
 Because glycol ethers are relatively simple chemicals in terms of structure, we next 
sought to visualize the relationships among them using a high-dimensional dataset of 2D 
chemical structure descriptors that are commonly used to develop quantitative structure 
activity models. Rather than isolating specific functional groups, we used molecular 
descriptors that are a mathematical interpretation from the transformation of chemical 
information into an encoded representation of a molecule. This was done using the SMILES 
code for the major isomers, where applicable.  Each compound is described by quantitative 
structural attributes developed for the purpose of providing a standardized description of 
structural properties that are common across chemicals and can be used to model structure-
based commonalities and provide a chemical basis for potential toxicity relationships.  
Figure 3 depicts a 2D approximation of the relative distance between all 16 
compounds in a 85- (CDK descriptors) or 535- (Dragon descriptors) dimensional space using 
principal components analysis. The CDK descriptors (Figure 3A) show more than 84% of the 
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variation can be accounted for by the first two principal components, separating spatially first 
by glycol unit quantity, and then by series (P- vs. E-). Very similar trends were observed 
when using a different set of molecular descriptors. Dragon descriptor-derived visualization 
(Figure 3B) shows that most similarity among compounds is determined by the number of 
glycol units (mono-, di-, tri-) in the first principal component (explaining over 67% of the 
variability), and then by the series (P- vs. E-) in the second principal component (explaining 
an additional 14%). Combined, the first two components describe much of the variation 
(>81%) in the data.  
 
 
 
Figure 3. Principal component analyses for combined glycol ethers. The Chemistry Development Kit (A) 
provided descriptors which describe over 84% of the variance within the first two components. The DRAGON 
PCA (B) accounts for over 81% within the first two components.  Chemical groupings are described in the inset 
legend by the glycol ether series (P: circle; E: square), as well as by structure: mono- (blue), di-(green), and tri-
(red) glycols.   
A B 
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3.3. Combined Biological and Chemical Similarity 
While ToxPi and PCA demonstrated concordance between biological and chemical-
based similarity, they were most useful for identifying the groupings (or categories) within 
the selected compounds and classes. These are less useful in selecting single analogue(s) for 
read-across. Thus, we used another type of integrative analysis, an approach of chemical-
biological read-across (Low et al., 2013). CBRA infers a compound's activity from those of 
its chemical and biological analogs. By directly relying on the experimentally-obtained 
biological measurements, as well as inherent physicochemical properties, the result is a 
computed similarity score based on other agents in the dataset and produces a radial plot 
showing the relative distance to the closest chemical “neighbors.” 
As opposed to groupings in ToxPi and PCA, CBRA allows for identification of most 
suitable “source” compounds (outer compounds) for any given “target” (the center of the 
radial plot). In the CBRA plot outputs (Figure 4), the left side represents the biologically 
similar compounds, while the right side shows the nearest neighbors with respect to chemical 
similarity, both calculated using the Tanimoto coefficient. The closer a chemical is to the 
center of the plot (i.e., to the “target” compound), the higher the Tanimoto coefficient, the 
more similar the two compounds are. The chemical abbreviation’s accompanying shape and 
color corresponds to its known category assignment for the two parameters: glycol ether 
series type and chemical structure/composition (color). CBRA plots show that the nearest 
neighbors in chemical space tend to follow chemical composition (i.e., the number of glycol 
units, mono-, di-, tri-) rather than series, while the biological similarity echoes the ToxPi-
derived rankings. The closest chemical neighbors also reflect the spatial distribution from the 
Dragon PCA plot (Figure 3B) from which the chemical component was sourced.  
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Figure 4. Selected CBRA radial plots. Figures A-D represent an individual chemical and their biologically 
closest (left) and chemically closest (right) neighbors. The color and shape accompanying the chemical 
abbreviation represent series (P: circle; E: square), as well as structure: mono- (blue), di-(green), and tri-(red) 
glycols, as presented in the inset legend. This also was applied to identify the chemical neighbors radiating from 
the plot’s center. The distance is determined by the Tanimoto coefficient, therefore the shorter the distance to 
the center, the larger the coefficient, the more similar the compound is to the one of interest. Figure 4A and 4B 
represent a relatively similar prediction for the nearest neighbors, both identifying acceptable candidates also of 
the mono- class and of the same series. PGME (4A) shows the nearest biological neighbor being an E-series 
chemical, while EGEE (4B) follows the expected biological profile its most similar neighbor being an E-series 
mono-glycol. Figure 4C shows the radial plot for TPGME with the nearest neighbors in biological and chemical 
space as predominantly other P-series compounds. The nearest neighbor for DEGME (4D) in chemical space is 
another E-series di-glycol, which is also present as a close neighbor in biological space. 
A PGME EGEE 
DEGME TPGME 
B 
C D 
P-series 
E-series 
Mono-glycol 
Di-glycol 
Tri-glycol 
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For example, Figure 4B shows that for a relatively more toxic compound within the 
dataset, EGEE, other E-series mono-glycols (blue squares) are included in the nearest 
neighbors with respect to both biological (left side) and chemical (right side) space. This 
echoes what is seen in the separate biological and chemical analyses, but is presented in a 
comprehensive figure.  Figure 4C shows TPGME, a relatively nontoxic compound. Nearly 
all of the nearest neighbors in biological and chemical space are other P-series compounds, 
reaffirming that the P-series group as relatively less toxic than the E-series. The analysis for 
DEGME (Figure 4D) does provide potential for a chemical similarity argument, however the 
biological nearest neighbor is a P-series mono-glycol. Though the closest biological neighbor 
PGBE does have a relatively high Tanimoto coefficient score, it is still important to note the 
toxicity profile associated with the two compounds. While DEGME has low biological 
activity across a variety of toxicity categories, the PGBE profile is dominated by the 
Irritation category, something that DEGME is lacking. This further emphasizes the 
importance of a holistic and judicious evaluation of both chemical and biological similarity. 
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4. CONCLUSIONS 
Programs such as ToxPi and CBRA have clear utility for category elucidation and 
formation, as well as comparative analyses within and across a product category. There are 
caveats and data considerations involved in constructively making use of these applications. 
A driving factor for any comparison is having a complete, or near-complete, dataset for the 
subjects of interest. Therefore, a hindrance to an informative output may be attributed to the 
diversity and inclusivity of data or lack thereof. Variations between study designs and 
endpoints observed can lead to a mismatched or incompatible dataset, which may produce a 
less informative representation as well as echo a need for broad and concurrent method 
standardization. When using a tool such as ToxPi, gaps in a dataset may pose an area for 
debate. Many compounds that have been screened resulted in no adverse effect observed, 
meaning they were pushed to the highest concentration or dose of the study, whether in vitro 
or in vivo, and had no negative effect observed. While this may be good news for a 
manufacturer, it leaves a large comparison study at a loss. The question arises on how to use 
the known data in the most informative, yet accurate, representation. Since no effect was 
seen, some may argue the endpoint value be purposefully left blank as not to attribute non-
existent toxicity at the highest dose tested.  A case can also be made for adding in the no 
observable adverse effect level (NOAEL) to complete the table, or the maximum tested dose 
to represent that there is no observed adverse effect at least up to that dose point. Since one 
can’t be sure how high the dose could continue to produce no effect without a proper dose-
response or point of departure analysis, expert judgement and documentation of the methods 
taken becomes a necessity. Leaving the data point blank decreases the predictive capabilities 
of the generated output since the lack of response is now in the same undefined nebulous 
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alongside the untested and potentially potent compounds. This leads to restrictions based on 
the individual study design and is apparent when combining various sources ranging across 
design and time.  
CBRA application handles a lack of information in a slightly different way. Since the 
comparison is done with a Tanimoto coefficient comparing similarity and doesn’t include a 
ranking, a missing data point doesn’t affect an overall score, simply a less confident 
prediction in the most similar compounds to the one of interest. Another invitation for open 
communication between stakeholders arises with multiple data entries available for a certain 
chemical and endpoint. Should one use the most recent study, the study with the largest 
sample size, or the most conservative reported value? It is also important to note that 
compounds may have a similar ToxPi score, yet very different toxicity profiles. The holistic 
approach presented by ToxPi builds not only individual profiles, but identifies a bigger 
picture which may point to otherwise-overlooked trends in biological activity. The profile, 
score, and ranking all serve to emphasize the benefits of a multi-visual output. There are 
advantages and disadvantages to weighting options. In this study we chose to weight 
endpoints equally, with slice weight reflecting the number of endpoints. By assigning equal 
weight to all parameters, the acute toxicity as well as irritation data have the same impact on 
the overall toxicity profile. Depending on the priorities of stakeholders, preferential 
weighting may be assigned to a specific slice or category in ToxPi.  
 This glycol ether case study provided a relatively data-rich platform to work from, 
however even a data-limited compound may be of utility. When compared to a set for which 
there is a subjectively sufficient amount of associated data, the data-limited substance can be 
added, analyzed with ToxPi, and the resultant profile may help identify what category or 
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toxicity profile grouping it would best fall into. This would be an applicable method for a 
read-across type approach. Given a wide variety of known relatively toxic and non-toxic 
compounds, such as utilizing ToxCast data, one could incorporate a wide variety of 
parameters to build and visualize unique profiles of toxicity. When compared to a diverse 
and stratified set, even a partial match for a data-limited chemical may be useful in gauging 
potential bioactivity, groupings, trends, overall characterization, or direct future study. 
Similarly, such data could also be supplemented into CBRA, which in addition, would make 
use of its physicochemical properties to assign similarity to others within that set, giving 
another dimension for read-across comparison to establish sufficient comparability. These 
applications, particularly CBRA, can also be of use for emerging types of data, such as –
omics results or “big data.” A multitude of endpoints from in vivo, in vitro, and in silico can 
be entered into the biological CBRA component to aid in a read-across type approach for 
categorization based on combined chemical and biological similarity for a registration 
application. These tools are not intended to replace traditional methods, but rather an addition 
to strengthen a weight-of-evidence approach, increasing the confidence towards producing a 
quality assessment.  
By allowing diverse data types to be used in conjunction, a global similarity can be 
evaluated, alongside the traditional endpoint-specific similarity. This analysis aimed to utilize 
ToxPi for clustering similarly-active compounds and identifying potential chemical drivers 
for the trend. Though some compounds showed similarity (for example, many butyl ethers 
scoring highly for Irritation Toxicity), the results highlight the importance of using less 
traditional data in conjunction to chemical description where available.  This case study used 
very structurally comparable compounds, both within and across the glycol ether series’. The 
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wide spread of biological responses for standard endpoints emphasizes the need to look past 
simple chemical structure and incorporate biological activity profiles as much as possible in 
decision making. This urges caution in the future application of read-across, and may 
questions the benefit in cases it has been used previously. This relatively data-rich package 
also exposed where similarity could be drawn if additional endpoints or information were not 
available, thus creating artificial support for certain endpoints/chemicals being good 
candidates for read-across. Though this workflow presents transparent biological, chemical, 
and combined biological/chemical evaluation, moreover it has shown that relatively data-
rich, structurally-similar compounds may not lend themselves to strictly biological or 
chemical grouping. Further showing that even an archetypal dataset fitting read-across 
criteria requires complex consideration and may not produce a touchstone for utility. These 
tools allow the integration and visualization of fundamental properties, historical in vivo 
endpoints, as well as novel data types to build an informative, comprehensive approach to 
integrated chemical classification and read-across categorization. 
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APPENDIX 
 
Table A-1. GHS-like transformation criteria. Rescaling criteria applied to the Mammalian 
Toxicity data. Each category had distinct specified endpoints, as seen in Table 2, and for 
those endpoint values, the chart below was used to rescale the data into a [0, 1] ToxPi format. 
(*) Denotes endpoints where the data were available in a Boolean Yes/No format. 
Additional, non-Boolean, Reproductive endpoints follow the Developmental Toxicity scale.  
 
Toxicity Category Transformation Criteria 
Category 1= 1; Category 2 = .75; Category 3 = 0.5; Category 4= 0.25; Category 5=0 
Acute Toxicity 
Oral: ≤5 = 1; ≤50 = 0.75; ≤300 = 0.5; ≤2000 = 0.25; >2000 = 0  
Inhalation: ≤100 = 1; ≤500 = 0.75; ≤2500 = 0.5; ≤5000 = 0.25; >5000 = 0 
Dermal: ≤50 = 1; ≤200 = 0.75; ≤1000 = 0.5; ≤2000 = 0.25; >2000 = 0 
Repeat Dose Toxicity NOEL <30 = 1; <100 = 0.75; <300 = 0.5; <1000 = 0.25; >1000 = 0 
Developmental Toxicity NOEL <30 = 1; <100 = 0.75; <300 = 0.5; <1000 = 0.25; >1000 = 0 
Reproductive Toxicity* Yes=1; No=0 
Skin and Eye Irritation: None=0; Slight=.25; Slight to Moderate=.5; Moderate=.75; Severe=1 
Skin Sensitization* Yes = 1, No = 0 
 
